New SEC Form D filing
Iambic Therapeutics, Inc., 2026-09-09
A new SEC Form D private-offering notice from San Diego, CA, a $66,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
AI driven drug discovery company developing cancer therapeutics using its Enchant and NeuralPLexer machine learning platforms
New filing todayFiled to raise $66,500,000First money in 2026-08-14Raised so far $65,965,000HQ (as filed) San Diego, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Debt-only offering
Source linked the Form D on EDGAR↗Website verified iambic.ai↗Named in the filing 13 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Fair Shake Saddlehorn, LLC, 2026-09-09, $2.5M, Santa Barbara, CA
- Cloverleaf Bio, Inc., 2026-09-09, $29.6M, New Haven, CT
- Litewave.AI, Inc, 2026-09-09, $3M, San Francisco, CA
- Animal Biosciences, Inc., 2026-09-09, $2.6M, Boston, MA
- Celero Communications, Inc., 2026-09-09, $275M, Irvine, CA
- Airway Therapeutics, Inc., 2026-09-09, $50.6M, Marietta, GA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.